(Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial - https://doi.org/10.1007/s13555-023-00995-z) -
(Emerging Medical Therapies in Rosacea: A Narrative Review - https://doi.org/10.1007/s13555-023-01048-1) -
(The Diagnostic Workup, Screening, and Treatment Approaches for Patients with Delusional Infestation - https://doi.org/10.1007/s13555-023-01053-4) -
(A Mini Review of the Impact of Baseline Disease Severity on Clinical Outcomes: Should We Compare Atopic Dermatitis Clinical Trials? - https://doi.org/10.1007/s13555-023-01052-5) -
(Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with Psoriasis - https://doi.org/10.1007/s13555-023-01060-5)